NEW
YORK, June 18, 2024 /PRNewswire/ -- The
global smoking cessation and nicotine de-addiction
market size is estimated to grow by USD
36.98 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 15.84%
during the forecast period. Rising adoption of online
retailing is driving market growth, with a trend
towards new marketing initiatives. However, health issues
associated with smoking cessation products poses a challenge.
Key market players include Alchem International Pvt. Ltd., Alkalon
AS, Alvogen Iceland ehf, Axcentria Pharmaceuticals, British
American Tobacco Plc, Cambrex Corp., CHEMNOVATIC Sp. Z o.o. Sp. K,
Cipla Inc., Dr Reddys Laboratories Ltd., Enorama Pharma AB,
Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson
Services Inc., Lil Drug Store Products Inc., Perrigo Co. Plc,
Pfizer Inc., Philip Morris International Inc., Qnovia, Tvape, and
Walgreens Boots Alliance Inc..
Get a detailed analysis on regions, market segments, customer
landscape, and companies- View the snapshot of this report
Smoking Cessation
And Nicotine De-Addiction Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
15.84%
|
Market growth
2024-2028
|
USD 36983.3
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
13.32
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
30%
|
Key
countries
|
US, Germany, China,
Canada, and India
|
Key companies
profiled
|
Alchem International
Pvt. Ltd., Alkalon AS, Alvogen Iceland ehf, Axcentria
Pharmaceuticals, British American Tobacco Plc, Cambrex Corp.,
CHEMNOVATIC Sp. Z o.o. Sp. K, Cipla Inc., Dr Reddys Laboratories
Ltd., Enorama Pharma AB, Imperial Brands Plc, Japan Tobacco Inc.,
Johnson and Johnson Services Inc., Lil Drug Store Products Inc.,
Perrigo Co. Plc, Pfizer Inc., Philip Morris International Inc.,
Qnovia, Tvape, and Walgreens Boots Alliance Inc.
|
Market Driver
Vendors in the smoking cessation and nicotine de-addiction
market are implementing innovative advertising strategies to
attract consumers. Notable examples include JUUL's first television
campaign, which showcased adult testimonials from ex-smokers aged
37 to 54 years. The campaign, titled "Taste Test Drive," featured
Dale Earnhardt Jr. Discussing his
personal smoking struggles and quitting journey. Such initiatives
are expected to expand the global market for smoking cessation and
nicotine de-addiction during the forecast period.
The Nicotine De-Addiction and Smoking Cessation market is
experiencing significant growth due to increasing awareness and
efforts to reduce the use of tobacco products. Neurotransmitters
like Nicotine are the primary drivers of this market. Companies are
focusing on developing innovative chronic disease management
solutions, such as Chantix and Nicotine Replacement Therapies
(NRTs). These solutions aim to help individuals quit smoking by
addressing the underlying addiction to Nicotine. Additionally, the
use of technology, such as mobile apps and wearable devices, is on
the rise in this market. These tools provide personalized support
and real-time tracking to help individuals manage their addiction
and quit smoking. The market is also witnessing an increase in the
use of Cytisinicline, a smoking cessation drug, and various other
smoking cessation methods like Hypnosis and Acupuncture. The market
is expected to continue growing as more individuals seek to improve
their health and quit smoking.
Research report provides comprehensive data on impact of trend.
For more details- Download a Sample Report
Market Challenges
- The smoking cessation and nicotine de-addiction market may
experience hindrances due to increasing awareness regarding the
potential health risks associated with nicotine gums, patches,
lozenges, and e-cigarettes. Long-term use of nicotine gums can lead
to health issues such as hair loss, skin irritation, elevated blood
pressure, irregular heartbeat, insulin resistance, gastrointestinal
problems, and nausea. Nicotine patches can cause skin irritation,
itching, dizziness, and headache. E-cigarettes contain toxic
ingredients like propylene glycol and vegetable glycerin, and
produce harmful chemicals such as acetaldehyde, acrolein, and
formaldehyde, which can lead to lung and cardiovascular diseases.
These health concerns may deter consumers from adopting these
products, thereby impacting market growth.
- The Smoking Cessation and Nicotine De-Addiction market faces
several challenges. Chronic use of cigarettes leads to nicotine
dependence, a significant issue in this market. Drugs like Chronic,
Cytisinicline, and Varenicline are used for nicotine replacement
therapy. However, their effectiveness varies from person to person.
Irritability and difficulty concentrating are common side effects,
making it crucial to manage patient expectations. Additionally, the
cost of these treatments can be a barrier for many individuals
seeking help. The market also requires innovative solutions to
address the psychological aspects of nicotine addiction. The use of
behavioral therapies, mobile apps, and telemedicine services can
help increase accessibility and affordability. Overall, the Smoking
Cessation and Nicotinic De-Addiction market requires a
multi-faceted approach to address the challenges of nicotine
addiction effectively.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This smoking cessation and nicotine de-addiction market report
extensively covers market segmentation by
- Distribution Channel
- 1.1 Drug stores and retailers
- 1.2 Hospital pharmacies
- 1.3 Online retail
- Product
- 2.1 E-cigarette
- 2.2 NRT
- 2.3 Drug therapy
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Drug stores and retailers- The drug stores
and retailers segment remains a significant player in the global
smoking cessation and nicotine de-addiction market in 2023.
Technological advancements and enhanced customer service at leading
pharmacies foster customer loyalty. These businesses keep consumers
informed about treatments and ensure seamless access to quality
pharmaceuticals. However, sales in this sector have been decreasing
due to the rise of online shopping. To boost offline sales, vendors
are expanding into local and regional markets, selling through
specialty stores and other retail formats. This trend intensifies
market competition, leading to moderate growth in segment revenue
during the forecast period.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data
(2017-2021) - Download a Sample Report
Research Analysis
The Smoking Cessation and Nicotine De-Addiction Market
encompasses a range of products and therapies designed to help
individuals quit tobacco use. These include nicotine replacement
therapies (NRTs) such as lozenges, gums, sprays, transdermal
patches, sublingual tablets, and inhalers. Drug therapy options,
like Zyban and Chantix, which are not nicotine-based but work by
affecting neurotransmitters, are also part of this market.
Non-nicotinic pharmacological therapies, such as bupropion and
varenicline, are another category. Behavioral therapies, including
counseling, are additionally utilized in smoking cessation efforts.
A recent Phase III study, ORCA-3, focused on the use of cytisine,
an alkaloid found in the laburnum plant, as a potential smoking
cessation aid. Drug Class Insights and Achieve Life Sciences are
among the entities providing insights and innovations in this
domain, working towards the development of effective and safer
solutions for chronic disease prevention through nicotine
de-addiction.
Market Research Overview
The Smoking Cessation and Nicotine De-Addiction market
encompasses a range of solutions designed to help individuals quit
smoking and reduce their dependence on nicotine. These offerings
include therapeutic approaches such as behavioral therapy, nicotine
replacement therapy (NRT), and pharmacological interventions.
Additionally, innovative technologies like mobile apps, wearable
devices, and telehealth services are gaining popularity in this
market. The market is driven by the growing awareness of the health
risks associated with smoking and the desire to improve overall
well-being. Furthermore, the increasing prevalence of nicotine
addiction and the availability of various treatment options are
fueling market growth. The market is expected to continue expanding
as more effective and accessible solutions emerge.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Distribution Channel
-
- Drug Stores And Retailers
- Hospital Pharmacies
- Online Retail
- Product
-
- E-cigarette
- NRT
- Drug Therapy
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/smoking-cessation-and-nicotine-de-addiction-market-size-is-set-to-grow-by-usd-36-98-billion-from-2024-2028--rising-adoption-of-online-retailing-boost-the-market-technavio-302174031.html
SOURCE Technavio